JPS5538366A - Intermediate for synthesizing novel azacycloalkane compound - Google Patents

Intermediate for synthesizing novel azacycloalkane compound

Info

Publication number
JPS5538366A
JPS5538366A JP15404878A JP15404878A JPS5538366A JP S5538366 A JPS5538366 A JP S5538366A JP 15404878 A JP15404878 A JP 15404878A JP 15404878 A JP15404878 A JP 15404878A JP S5538366 A JPS5538366 A JP S5538366A
Authority
JP
Japan
Prior art keywords
synthesizing novel
compound
azacycloalkane compound
novel azacycloalkane
synthesizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP15404878A
Other languages
English (en)
Inventor
Henrii Oruzaisu Toomasu
Aamon Haabaato Chiyaaruzu
Rosu Jiyonson Maikeru
Shiyaaman Merubin Jiy Roorensu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of JPS5538366A publication Critical patent/JPS5538366A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/48Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epoxy Compounds (AREA)
JP15404878A 1977-09-13 1978-12-13 Intermediate for synthesizing novel azacycloalkane compound Pending JPS5538366A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/832,869 US4147872A (en) 1977-09-13 1977-09-13 3-[2-Hydroxy-4-(substituted)-phenyl]azacycloalkanes and derivatives thereof as analgesic agents and intermediates therefor

Publications (1)

Publication Number Publication Date
JPS5538366A true JPS5538366A (en) 1980-03-17

Family

ID=25262819

Family Applications (5)

Application Number Title Priority Date Filing Date
JP53112171A Expired JPS5935397B2 (ja) 1977-09-13 1978-09-12 新規なアザシクロアルカン化合物
JP15404578A Granted JPS5495577A (en) 1977-09-13 1978-12-13 Novel azacycloalkane compound and medical composition containing it
JP15404878A Pending JPS5538366A (en) 1977-09-13 1978-12-13 Intermediate for synthesizing novel azacycloalkane compound
JP15404678A Pending JPS5492973A (en) 1977-09-13 1978-12-13 Intermediate for synthesis of novel azacycloalkane compound
JP15404778A Pending JPS5538365A (en) 1977-09-13 1978-12-13 Intermediate for synthesizing novel azacycloalkane compound

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP53112171A Expired JPS5935397B2 (ja) 1977-09-13 1978-09-12 新規なアザシクロアルカン化合物
JP15404578A Granted JPS5495577A (en) 1977-09-13 1978-12-13 Novel azacycloalkane compound and medical composition containing it

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP15404678A Pending JPS5492973A (en) 1977-09-13 1978-12-13 Intermediate for synthesis of novel azacycloalkane compound
JP15404778A Pending JPS5538365A (en) 1977-09-13 1978-12-13 Intermediate for synthesizing novel azacycloalkane compound

Country Status (23)

Country Link
US (1) US4147872A (ja)
JP (5) JPS5935397B2 (ja)
AR (2) AR222019A1 (ja)
AT (1) AT368753B (ja)
AU (1) AU507953B1 (ja)
BE (1) BE870403A (ja)
CA (1) CA1113463A (ja)
CH (1) CH638187A5 (ja)
DE (1) DE2839883A1 (ja)
DK (1) DK401078A (ja)
ES (2) ES473287A1 (ja)
FI (1) FI66173C (ja)
FR (4) FR2401913A1 (ja)
GB (1) GB2004548B (ja)
IE (1) IE47717B1 (ja)
IL (1) IL55555A (ja)
IT (1) IT1099026B (ja)
LU (1) LU80219A1 (ja)
NL (1) NL7809272A (ja)
PH (1) PH15372A (ja)
PT (1) PT68542A (ja)
SE (2) SE7809606L (ja)
YU (1) YU215678A (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
FI792076A (fi) * 1978-07-05 1980-01-06 Ciba Geigy Ag Foerfarande foer framstaellning av nya fenylpiperidinderivat
US4216218A (en) * 1979-02-23 1980-08-05 American Hoechst Corporation Antidepressant and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines
US4312876A (en) * 1979-02-23 1982-01-26 Hoechst-Roussel Pharmaceuticals Incorporated Antidepressive and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines
US4302590A (en) * 1979-02-23 1981-11-24 Hoechst-Roussel Pharmaceuticals, Inc. Intermediates for the preparation of 4-aryloxy-3-phenylpiperidines
ZA821888B (en) * 1981-04-01 1983-02-23 Haessle Ab Novel phenyl-piperidines
US4709016A (en) * 1982-02-01 1987-11-24 Northeastern University Molecular analytical release tags and their use in chemical analysis
US4529732A (en) * 1983-03-14 1985-07-16 Pfizer Inc. 2-[2-Hydroxy-4-(substituted)phenyl]piperidines
FI864570A0 (fi) * 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
US20040087590A1 (en) * 2002-08-23 2004-05-06 University Of Connecticut Novel biphenyl and biphenyl-like cannabinoids
DE102004036349A1 (de) * 2004-07-27 2006-03-23 Grünenthal GmbH Substituierte 3-Phenylpiperidin-Derivate
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑-磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2014125233A2 (fr) 2013-02-14 2014-08-21 Galderma Research & Development Procédé de synthèse de 4-piperidin-4-yl-benzène-1,3-diol et de ses sels et nouveau composé 4-(2,4-dihydroxy-phényl)-4-hydroxy-piperidine-1-carboxylate de tert-butyle

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2310761A1 (fr) * 1975-05-16 1976-12-10 Roussel Uclaf Nouveaux derives de la phenyl-piperidine et leurs sels, procede de preparation et application a titre de medicaments

Also Published As

Publication number Publication date
DE2839883A1 (de) 1979-03-15
AR222019A1 (es) 1981-04-15
ES480151A1 (es) 1980-04-01
IT1099026B (it) 1985-09-18
FI782793A (fi) 1979-03-14
IL55555A0 (en) 1978-12-17
FR2412531A1 (fr) 1979-07-20
DK401078A (da) 1979-03-14
CH638187A5 (fr) 1983-09-15
JPS5495577A (en) 1979-07-28
FR2412529B1 (ja) 1983-01-14
NL7809272A (nl) 1979-03-15
FR2412530B1 (ja) 1982-11-12
SE8305422D0 (sv) 1983-10-03
AR220567A1 (es) 1980-11-14
ES473287A1 (es) 1980-03-01
IT7827557A0 (it) 1978-09-12
IE781837L (en) 1979-03-13
JPS5640155B2 (ja) 1981-09-18
IL55555A (en) 1982-08-31
JPS5492973A (en) 1979-07-23
FR2401913A1 (fr) 1979-03-30
IE47717B1 (en) 1984-05-30
YU215678A (en) 1983-06-30
FR2412529A1 (fr) 1979-07-20
JPS5935397B2 (ja) 1984-08-28
BE870403A (fr) 1979-03-12
FI66173C (fi) 1984-09-10
JPS5538365A (en) 1980-03-17
GB2004548A (en) 1979-04-04
FR2401913B1 (ja) 1983-01-21
CA1113463A (en) 1981-12-01
US4147872A (en) 1979-04-03
SE8305422L (sv) 1983-10-03
SE7809606L (sv) 1979-03-14
AT368753B (de) 1982-11-10
JPS5463086A (en) 1979-05-21
FR2412530A1 (fr) 1979-07-20
ATA658078A (de) 1982-03-15
AU507953B1 (en) 1980-03-06
FR2412531B1 (ja) 1983-01-14
LU80219A1 (fr) 1980-04-21
GB2004548B (en) 1982-03-24
PT68542A (en) 1978-10-01
FI66173B (fi) 1984-05-31
PH15372A (en) 1982-12-10

Similar Documents

Publication Publication Date Title
JPS5489041A (en) Myrbemicine compound as vermicide
JPS5538366A (en) Intermediate for synthesizing novel azacycloalkane compound
JPS55111413A (en) Composition for mouthcavity
JPS5490142A (en) Compound
PT68689A (en) Novel compositions
JPS53130644A (en) 11aminoindane compound
JPS53134894A (en) Process for producing pvppiodine compound
JPS57154198A (en) Intermediate for novel antibacterial
JPS5452081A (en) Sulfonylamidine compound
JPS54160382A (en) 44pyrone compound
JPS5419974A (en) Novel organic compound
JPS5441857A (en) 22indanamine compound
JPS53135978A (en) Substituted bissbenzimidazolyl compound
JPS5585586A (en) Novel indole compound
JPS5422400A (en) Novel imidazooisoquinolineedione compound
JPS567790A (en) Novel penicillinn1*11dioxide compound
JPS53137991A (en) Novel betaalactum compound
JPS5455585A (en) Novel 1*44 dihydropiridazine compound
ZA781173B (en) Novel compositions
JPS5422360A (en) Antibiotic compound
JPS53137989A (en) Novel betaalactum compound
JPS53119871A (en) Process for preparing 22hydroxybenzothiazole compound
JPS55147293A (en) Novel thiazolinoazetidinone compound
JPS5444699A (en) Antibiotic compound
JPS545908A (en) Novel process for preparing organogold compound and intermediate